sapropterin has been researched along with Left Ventricular Hypertrophy in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bai, F; Chang, P; Li, X; Lin, X; Wang, Q; Xu, H; Yang, M; Yu, J; Zhang, X; Zhang, Z; Zhao, F; Zhao, X | 1 |
Fujita, M; Iwasaka, T; Otani, H; Shimazu, T; Shiojima, I; Yoshioka, K | 1 |
Bedja, D; Carnicer, R; Casadei, B; Channon, KM; Duglan, D; Hahn, VS; Hashimoto, T; Kass, DA; Recalde, A; Sivakumaran, V; Zhu, G | 1 |
Arkenbout, EK; Barker, N; Barouch, LA; Bedja, D; Champion, HC; Channon, KM; Chen, J; Cingolani, O; Gabrielson, KL; Hale, AB; Halushka, MK; Kaminski, PM; Kass, DA; Leyton-Mange, JS; Moens, AL; Niu, X; Wolin, MS; Wuyts, FL; Xia, Y; Yang, R | 1 |
Alp, NJ; Channon, KM; Kass, DA; Ketner, EA; Moens, AL; O'Neill, CA; Schmidt, TS; Takimoto, E; Wolin, MS | 1 |
Dunster, C; Grieve, DJ; Kelly, FJ; Li, JM; MacCarthy, PA; Shah, AM | 1 |
6 other study(ies) available for sapropterin and Left Ventricular Hypertrophy
Article | Year |
---|---|
Tetrahydrobiopterin reverse left ventricular hypertrophy and diastolic dysfunction through the PI3K/p-Akt pathway in spontaneously hypertensive rats.
Topics: Animals; Biopterins; Blood Pressure; Body Weight; Diastole; Hypertension; Hypertrophy, Left Ventricular; Male; Organ Size; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles; Valine; Valsartan | 2015 |
Sepiapterin prevents left ventricular hypertrophy and dilatory remodeling induced by pressure overload in rats.
Topics: Animals; Aorta; Biopterins; Capillaries; Cell Size; Constriction; Dilatation, Pathologic; Enzyme Inhibitors; Glycine; Heart; Hypertrophy, Left Ventricular; Male; Myocardium; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organ Size; Oxidative Stress; Pressure; Pterins; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds; Ultrasonography; Ventricular Dysfunction, Left; Ventricular Remodeling | 2015 |
Tetrahydrobiopterin Protects Against Hypertrophic Heart Disease Independent of Myocardial Nitric Oxide Synthase Coupling.
Topics: Animals; Anti-Inflammatory Agents; Biopterins; Cardiovascular Agents; Cytokines; Cytoprotection; Disease Models, Animal; GTP Cyclohydrolase; Humans; Hypertrophy, Left Ventricular; Inflammation Mediators; Macrophages; Mice, Transgenic; Myocytes, Cardiac; Nitric Oxide; Nitric Oxide Synthase; Oxidation-Reduction; Signal Transduction; Superoxides; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2016 |
Adverse ventricular remodeling and exacerbated NOS uncoupling from pressure-overload in mice lacking the beta3-adrenoreceptor.
Topics: Age Factors; Animals; Biopterins; Blotting, Western; Cardiomyopathies; Echocardiography; Hypertrophy, Left Ventricular; Male; Mice; Mice, Mutant Strains; Nitric Oxide Synthase; Oxidative Stress; Receptors, Adrenergic, beta-3; Superoxides; Vasoconstriction; Ventricular Remodeling | 2009 |
Bi-modal dose-dependent cardiac response to tetrahydrobiopterin in pressure-overload induced hypertrophy and heart failure.
Topics: Analysis of Variance; Animals; Biopterins; Cardiotonic Agents; Dose-Response Relationship, Drug; Heart Failure; Humans; Hypertrophy, Left Ventricular; Ligation; Mice; Mice, Inbred C57BL; Myocardium; Random Allocation; Superoxides; Ventricular Function, Left; Ventricular Remodeling | 2011 |
Impaired endothelial regulation of ventricular relaxation in cardiac hypertrophy: role of reactive oxygen species and NADPH oxidase.
Topics: Animals; Antioxidants; Arginine; Ascorbic Acid; Biopterins; Deferoxamine; Drug Synergism; Endothelium, Vascular; Free Radical Scavengers; Glutathione; Guinea Pigs; Heart Ventricles; Hypertrophy, Left Ventricular; In Vitro Techniques; Male; Malondialdehyde; Metalloporphyrins; Myocardial Contraction; NADPH Oxidases; Oxidation-Reduction; Reactive Oxygen Species; Substance P | 2001 |